Crossmark

Letter to the Editor Responding to “Paths Forward for Clinicians Amidst the Rise of Unregulated Clinical Decision Support Software: Our Perspective on NarxCare”

Crossref DOI link: https://doi.org/10.1007/s11606-024-08615-y

Published Online: 2024-01-18

Published Print: 2024-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Cochran, Gerald https://orcid.org/0000-0002-0153-0252
Brown, Jennifer L.

Winhusen, T. John
Funding

Funding for this research was provided by:

National Institute on Drug Abuse (UG1DA013732, UG1DA049444)
License Information

Text and Data Mining valid from 2024-01-18

Version of Record valid from 2024-01-18
More Information

Article History

Received: 7 December 2023

Accepted: 8 January 2024

First Online: 18 January 2024

Free to read: This content has been made available to all.

Document is current

Any future updates will be listed below